Yifang Li

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Topics

Systemic Sclerosis

Top Venues

British journal of pharmacology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Chrishan S Samuel, Yifang Li, Yan Wang, Robert E Widdop
Functional crosstalk between angiotensin receptors (types 1 and 2) and relaxin family peptide receptor 1 (RXFP1): Implications for the therapeutic targeting of fibrosis. British journal of pharmacology (2022)
Chrishan S Samuel, Yifang Li, Yan Wang, Robert E Widdop
AT 1 R-AT 2 R-RXFP1 functional crosstalk: implications for the therapeutic targeting of fibrosis. British journal of pharmacology (2022)
Yifang Li, Sharon D Ricardo, Chrishan S Samuel
Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease. International journal of molecular sciences 23 (11) (2022)